WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 1-December 2016 (data as of 18-November-2016)
Next overall update June 2017
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 4201 Infant (under 12 months) mortality rate: 292
GDP / capita (US$): 1'4591 Child (under 5 years) mortality rate: 402

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 24'235  23'572  22'925  22'294  21'679  15'745  11'546  8'747 
Births 831  814  797  781  765  648  524  389 
Surviving infants 804  786  769  751  735  604  469  345 
Pop. less than 5 years 3'770  3'686  3'606  3'528  3'454  2'841  2'113  1'647 
Pop. less than 15 years 10'108  9'910  9'718  9'529  9'341  7'164  5'211  4'054 
Female 15-49 years 5'867  5'681  5'497  5'317  5'143  3'609  2'627  1'915 

Number of reported cases

(Click for retrospective incidence data for Madagascar)
Diphtheria
ChartChart
  1'627  12  252  227 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  35'256  14'459  119'679 
Mumps
ChartChart
  12 
Pertussis
ChartChart
  413  19  33  369  3'880  1'333  32'457 
Polio*
ChartChart
  10  39  68 
Rubella
ChartChart
  89  162  131  110  196 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  13  43  13  208 
Tetanus (total)**
ChartChart
  200  131  556  490  728  54  208  842 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Madagascar)
Vaccine year result method % card seen                                                
BCG 2011  74     46  70  75  77  78  82  99*  98  21 
DTP1 2011  80     46  95  99  96  97  96  86 
DTP3 2011  63     46  85  89  90  86  89  80  71  48 
DTP4         
IPV1          30 
HepB_BD         
HepB3 2011  63     46  85  89  90  86  89 
Hib3 2011  63     46  85  89  90  86  89 
JapEnc         
MCV1          81  87  86  85  85  81  57 
MCV2         
PCV1          93  96  95  65 
PCV3          85  88  92 
Pol3 2011  63     46  86  88  88  86  88  81  69 
Rota1          87  67 
RotaC          80  50 
RCV1         
TT2plus          47  53  63  59  62  40  31 
PAB         
VAD1          94  91 
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Madagascar)
BCG
ChartChart
  70  75  77  78  82  72  67  21 
DTP1
ChartChart
  79  83  80  80  80  74  71 
DTP3
ChartChart
  69  73  74  70  73  57  46 
HepB3
ChartChart
  69  73  74  70  73 
HepB_BD
ChartChart
 
Hib3
ChartChart
  69  73  74  70  73 
IPV1
ChartChart
  30 
MCV1
ChartChart
  58  64  63  61  62  57  47 
MCV2
ChartChart
 
PAB
ChartChart
  78  78  78  78  78  58  45 
PCV3
ChartChart
  69  72  76 
Pol3
ChartChart
  71  73  73  71  73  58  46 
RCV1
ChartChart
 
RotaC
ChartChart
  69  39 

Number of districts in the country 112  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
99 
   
/
|
|
\
Greater or equal to 90% 42
From 80 to 89% 24
From 50 to 79% 33
Less than 50% 1
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
IPV 14 weeks; Yes
Measles 9 months; Yes
OPV Birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes
VitA 6-12 months; 12-59 months; Yes
VitaminA 6-12 months; 12-59 months; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2016-2019  2013-2016  2010-2015  2011-2015  2011-2015  2011-2015  2010-2014 
Nº of districts with microplans that include activities to raise immunization coverage number 112  112  112  112  112  111  111 

System performance

Total Nº districts in country number 112  112  112  112  112  111  111 
Nº districts with DTP3 coverage >=80% number 74  90  85  76  86  65  76 
% of districts with DTP3 coverage >=80% From 0 to 100% 66  80  76  68  77  59  68 
Nº districts with measles (MCV1) coverage >=95% number 18  39  34  25  21  41  30 
% of districts with MCV1 coverage >=95% From 0 to 100% 16  35  30  22  19  37  27 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 36    23  22 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  Yes  No   

Sources

 1  "The 2016 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.